Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Promontory Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Promontory Therapeutics

Promontory Therapeutics

Promontory Therapeutics Inc.: A clinical-stage pharma company innovating small molecule immunotherapies.

HQ
New York City, NY, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Promontory Therapeutics Inc. is a clinical-stage pharmaceutical company founded with the mission to innovate in the field of small molecule immunotherapies. The company's vision is to address unmet medical needs in oncology by developing novel anti-cancer agents. Their lead candidate, PT-112, is a highly potent immunogenic cell death (ICD) inducer currently in Phase clinical development. Promontory Therapeutics focuses on creating therapies that exhibit unique mechanisms of action, single-agent activity, and demonstrated safety.

Promontory Therapeutics has garnered attention in the biotech community, being nominated for the Prix Galien USA Best Startup. The company has made significant strides in advancing its lead candidate through clinical trials, showcasing its potential to revolutionize cancer treatment. With a dedicated team of experts and support from notable investors, Promontory Therapeutics continues to make impactful contributions to the field of oncology, aiming to provide new hope for patients with challenging cancer diagnoses.

Promontory Therapeutics - Similar Companies

Promiliad Biopharma logo

Promiliad Biopharma

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Starton Therapeutics logo

Starton Therapeutics

Promentis Pharmaceuticals logo

Promentis Pharmaceuticals

Promakhos Therapeutics logo

Promakhos Therapeutics

promakhos.com

Checkpoint Therapeutics logo

Checkpoint Therapeutics

checkpointtx.com

LTZ Therapeutics logo

LTZ Therapeutics

Xios Therapeutics logo

Xios Therapeutics

PNP Therapeutics logo

PNP Therapeutics

Dual Therapeutics logo

Dual Therapeutics

Pheast Therapeutics logo

Pheast Therapeutics

pheast.com

Pinpoint Therapeutics logo

Pinpoint Therapeutics

Nirogy Therapeutics logo

Nirogy Therapeutics

NextPoint Therapeutics logo

NextPoint Therapeutics

nextpointtx.com

Ostentus Therapeutics logo

Ostentus Therapeutics

Promontory Therapeutics - Quick Facts

Who are Promontory Therapeutics' competitors?

Companies similar to Promontory Therapeutics include Promiliad Biopharma, PTC Therapeutics, Starton Therapeutics and Promentis Pharmaceuticals.

When was Promontory Therapeutics founded?

Promontory Therapeutics was founded in 2010.

Where is Promontory Therapeutics' headquarters located?

Promontory Therapeutics' headquarters is located in New York City, NY, US.

When was Promontory Therapeutics' last funding round?

Promontory Therapeutics' most recent funding round was for $37M (USD) in December 2021.

How much has Promontory Therapeutics raised to-date?

As of Dec 14, 2021, Promontory Therapeutics has raised a total of $72M (USD).

How many employees does Promontory Therapeutics have?

Promontory Therapeutics has 26 employees as of Feb 4, 2024.

Promontory Therapeutics - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified